HOUSTON, January 3, 2019 / PRNewswire-PRWeb / – Texasbased on digital neurocognitive tests, raised US $ 1.5 million in additional capital to bring personalized medicine and AI to the care of dementia through its cognitive care management technology, BrainCheck Care, which launched on July 2018. The funding, led by, with participation from, and angel investors, brings the total funding to US $ 6 million To date.
Born in the Eagleman Neuroscience Laboratory in Baylor College of Medicine (now in StanfordBrainCheck allows physicians to quickly and accurately assess cognitive function and provide cognitive care in scale. The platform is currently used by hundreds of clinical practices and over 40,000 people and is growing rapidly. As the first to market with an end-to-end cognitive health solution, BrainCheck is well positioned to change millions of lives, providing a much needed and promising solution to the "Silver Tsunami".
There are in the USA today, according to the Alzheimer's Association. The cost to health organizations is 50% higher than cancer or heart disease. But new research from The Lancet Commission shows that one-third of dementia is preventable, and disease progression can be delayed by effective detection and by addressing modifiable risk factors. As digital medicine continues to transform patient care, BrainCheck occupies a unique position to meet the needs of the dementia market.
Through a combination of assessments, screeners, workflows and clinical decision support algorithms, BrainCheck Care allows physicians to provide a detailed and personalized care plan for the patient and caregiver at the point of care.
"BrainCheck's robust and robust data set on cognitive health, combined with other biometric and health data, allows us to customize care for dementia at scale," said BrainCheck co-founder and CEO. "For the first time, physicians and caregivers can see if interventions are working, tracking cognitive change for a patient's medications, chronic illnesses or lifestyle, and repeating these interventions to optimize outcomes."
ChicagoStock-based Voltage Partners focuses its investments on enterprise AI companies. "We saw a great opportunity with BrainCheck," he said. Armando Pauker, managing director and co-founder of Tensility Venture Partners. "They are seated in a treasure trove of hard-to-get data and are addressing a great market opportunity. They bring the power and benefits of AI to clinical care to make cognitive testing easily available to everyone."
"The research is clear and it is now clinically proven that patients can delay the onset of dementia," he said. Charlie Plauche, partner of S3 Ventures. "By helping doctors detect this debilitating disease early, BrainCheck's platform technology will improve the lives of millions of people in the coming years."
Headquartered at the Texas Medical Center Innovation Institute, TMCx, BrainCheck recently opened a second office in Austin, Texas. The funding will be used to expand the research and development of the company and increase its supply, which is actually moving the needle in the space of dementia. The company is also investing in sales and marketing talent to accelerate deployment in clinical practice.
BrainCheck provides rapid mobile cognitive assessment and decision support technology for physicians, enabling them to provide high quality, personalized cognitive health care to patients everywhere and to be reimbursed. This helps patients live a better and safer life at home, lessens the caregiver's frustration, and saves trillions of health care systems. Founded in 2015 by neuroscientists and technologists (Baylor College of Medicine/Stanfordand BrainCheck helps to decrease the human and economic impact of cognitive impairment and dementia through its interactive cognitive assessment and care management technology. BrainCheck is used around the world to detect early cognitive impairment and allow patients, caregivers, and clinicians to work together to implement personalized recommendations to preserve brain health and functional independence. BrainCheck allows doctors to pay for cognitive care management (through Medicare reimbursement) and simultaneously reduces healthcare costs by keeping patients healthy, safe, and out of the hospital.
To learn more, please visit.